Zzzhuan
Lv11
34 积分
2023-10-08 加入
-
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
1小时前
已完结
-
Discovery of Pyrazolo[1,5,4-de]quinoxalin-2(3H)-one Derivatives as Highly Potent and Selective PARP1 Inhibitors
6小时前
已完结
-
503LBA LBA Orals: Results from CA240-0007, a phase 1/2 multiple expansion cohort study of BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion (MTAP-del)
14天前
已完结
-
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
25天前
已完结
-
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
25天前
已完结
-
Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in Oncology
29天前
已完结
-
Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin‐Specific MKLP‐2 Inhibitor
1个月前
已完结
-
Reactivating antitumor immunity by inhibiting JMJD1C
1个月前
已完结
-
Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity
1个月前
已完结
-
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
1个月前
已完结